Business Strategy

Ablitech, Inc. is a biotechnology company dedicated to the development and commercializing of platform technologies that heal and protect the human body.

• Our strategy is to radicalize technology and revolutionize the current thinking of gene delivery therapy.

• Ablitech's Versadel therapy is a platform technology for treatment of a variety of diseases such as cancer, HIV, and other diseases resulting from genetic abnormalities. Initial development of this technology is focused on a pancreatic and bladder cancer therapy, but behold the possibilities.

• Interested in taking our positive results to the next phase, join us in pursuing animal testing. We are also looking for partners for development of Versadel antisense oligonucleotides for bone regeneration.